IPSC-DAPs

· iCamuno Biotherapeutics Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IPSC-DAPs, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease [Phase 1]